Doxazosin Tablet
Product Images NDC 71335-0309

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71335-0309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Doxazosin Fig1)

Table 1 (Doxazosin Fig1)
Table summarizing effectiveness data from placebo-controlled trials of Doxazosin, showing symptom score and maximum flow rate changes at various doses (placebo, 4 mg, 8 mg) across three studies. The table includes baseline means and mean changes, highlighting significant improvements in symptom scores and flow rates with Doxazosin compared to placebo.*
FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

Figure 1 – Study 1 (Doxazosin Fig2)
This image contains two line graphs comparing Doxazosin and placebo effects over 14 weeks. The left graph shows the mean change in total symptom score from baseline, with Doxazosin consistently reducing symptoms more than placebo. The right graph depicts the mean increase in maximum urinary flow rate (mL/sec) from baseline, showing greater improvement with Doxazosin than placebo. Both graphs include sample sizes and statistical significance indicators.*
FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical Structure (Doxazosin Str)
Chemical structure diagram of Doxazosin mesylate, showing its molecular components and chemical bonds.*
FDA Label Image

Label Image (Lbl713350309)

Label Image (Lbl713350309)
Label for Doxazosin Mesylate 2 mg tablet, packaged by Bryant Ranch Prepack in Burbank, CA. The label indicates the tablet is yellow, round, and marked with 'C7'. It references Cardura 2 mg tablet by Intas Pharmaceuticals Limited as a comparison. The package contains 30 tablets and includes storage instructions at 20°-25°C (68°-77°F) and a warning to keep drugs out of reach of children. The NDC on the label is 71335-0309-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.